Study highlights third-line treatment options for T2DM
(HealthDay)—Treatment escalation options have different efficacy following failure of exenatide or glimepiride added to metformin in patients with type 2 diabetes mellitus, according to a study published online April 1 ...
Apr 13, 2015
0
3